Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake.

This work consisted in defining the in vitro behavior of pegylated lipid nanocapsules (LNC) toward the immune system. LNC were composed of an oily core surrounded by a shell of lecithin and polyethylene glycol (PEG) known to decrease the recognition of nanoparticles by the immune system. The "stealth" properties were evaluated by measuring complement activation (CH50 technique and crossed-immunoelectrophoresis (C3 cleavage)) and macrophage uptake. These experiments were performed on 20-, 50-, and 100-nm LNC before and after dialysis. A high density of PEG at the surface led to very low complement activation by LNC with a slight effect of size. This size effect, associated to a dialysis effect in macrophage uptake, was due to differences in density and flexibility of PEG chains related to LNC curvature radius. Thanks to a high density, 660-Da PEG provided LNC a steric stabilization and a protective effect versus complement protein opsonization, but this protection decreased with the increase of LNC size, especially versus macrophage uptake.

[1]  Lisbeth Illum,et al.  Long circulating microparticulate drug carriers , 1995 .

[2]  R. Müller,et al.  Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. , 1987, Biomaterials.

[3]  T. Kinoshita.  Biology of complement: the overture. , 1991, Immunology today.

[4]  J. Benoit,et al.  The influence of lipid nanocapsule composition on their size distribution. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  Devine,et al.  The complement system in liposome clearance: Can complement deposition be inhibited? , 1998, Advanced drug delivery reviews.

[6]  M. Papisov,et al.  Why do Polyethylene Glycol-Coated Liposomes Circulate So Long?: Molecular Mechanism of Liposome Steric Protection with Polyethylene Glycol: Role of Polymer Chain Flexibility , 1994 .

[7]  S. Moghimi,et al.  Capture of stealth nanoparticles by the body's defences. , 2001, Critical reviews in therapeutic drug carrier systems.

[8]  I. Rubinstein,et al.  VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[9]  J. Benoit,et al.  Biodistribution of dual radiolabeled lipidic nanocapsules in the rat using scintigraphy and gamma counting. , 2002, International journal of pharmaceutics.

[10]  J. Kreuter,et al.  Colloidal Drug Delivery Systems , 1994 .

[11]  D. Bazile,et al.  Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. , 1996, Biomaterials.

[12]  Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptors. , 2001, Life sciences.

[13]  S. Nagaoka,et al.  Interaction Between Blood Components and Hydrogels With Poly(Oxyethylene) Chains , 1984 .

[14]  J. Benoit,et al.  A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers , 2002, Pharmaceutical Research.

[15]  Hideyoshi Harashima,et al.  Enhanced Hepatic Uptake of Liposomes Through Complement Activation Depending on the Size of Liposomes , 1994, Pharmaceutical Research.

[16]  Feng Liu,et al.  Antibody Dependent, Complement Mediated Liver Uptake of Liposomes Containing GM1 , 2004, Pharmaceutical Research.

[17]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[18]  J. Benoit,et al.  Complement Activation by Injectable Colloidal Drug Carriers , 2004 .

[19]  P. Ralph,et al.  Functional macrophage cell lines transformed by abelson leukemia virus , 1978, Cell.

[20]  E. Roux,et al.  Novel Long-Circulating Lipid Nanocapsules , 2004, Pharmaceutical Research.

[21]  D. Fischer,et al.  Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  Joseph D. Andrade,et al.  Protein—surface interactions in the presence of polyethylene oxide , 1991 .

[23]  D. Devine,et al.  Liposome-complement interactions in rat serum: implications for liposome survival studies. , 1994, Biochimica et biophysica acta.

[24]  R L Juliano,et al.  The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. , 1975, Biochemical and biophysical research communications.

[25]  Papisov.  Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions. , 1998, Advanced drug delivery reviews.

[26]  S. Davis,et al.  The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. , 2001, Biochimica et biophysica acta.

[27]  M. Kazatchkine,et al.  Specific antibodies enhance Sephadex-induced activation of the alternative complement pathway in human serum. , 1988, Biomaterials.

[28]  Alving Cr,et al.  Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity. , 1991 .

[29]  O. Bourdon,et al.  Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. , 2001, Biomaterials.

[30]  A. Hoffman,et al.  Water Structure of PEG Solutions by Differential Scanning Calorimetry Measurements , 1992 .

[31]  C. Passirani,et al.  Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. , 1998, Life sciences.

[32]  K. Goodrum,et al.  Complement Component C3 Secretion by Mouse Macrophage‐Like Cell Lines , 1987, Journal of leukocyte biology.

[33]  M. Bodó,et al.  The interaction of liposomes with the complement system: in vitro and in vivo assays. , 2003, Methods in enzymology.

[34]  J. Benoit,et al.  Electrokinetic properties of noncharged lipid nanocapsules: Influence of the dipolar distribution at the interface , 2005, Electrophoresis.

[35]  V. Kolb-Bachofen,et al.  Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. , 1993, Biochimica et biophysica acta.